×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Harsch Mutya

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCJan 02, 2024Option Exercise$2.28161367149,435Jan 03, 2024, 05:20 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCOct 02, 2023Option Exercise$3.831,1544,42024,596Oct 04, 2023, 04:21 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCMay 31, 2023Option Exercise$3.463,66412,66425,907Jun 02, 2023, 04:34 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCMar 20, 2023Buy$2.5010,00025,00022,721Mar 22, 2023, 04:01 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCDec 31, 2022Option Exercise$0.151,813272229,144Jan 04, 2023, 05:12 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCSep 30, 2022Option Exercise$0.221,813404230,957Oct 04, 2022, 05:04 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCJun 30, 2022Option Exercise$0.391,813705232,770Jul 05, 2022, 05:00 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCMar 31, 2022Option Exercise$0.653,6302,359234,583Apr 04, 2022, 05:09 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCDec 31, 2021Option Exercise$1.021,4841,514163,213Jan 04, 2022, 04:40 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCSep 30, 2021Option Exercise$1.391,4842,063164,697Oct 01, 2021, 05:11 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCJun 30, 2021Option Exercise$3.513,55112,464105,322Jul 02, 2021, 04:36 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCMar 31, 2021Option Exercise$6.841,76512,073108,873Apr 02, 2021, 12:14 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCDec 31, 2020Option Exercise$1.581,8222,879325,703Jan 05, 2021, 12:00 AM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCNov 30, 2020Option Exercise$1.4510,46015,115327,525Dec 02, 2020, 04:31 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCSep 30, 2020Option Exercise$1.661,8223,025317,065Oct 02, 2020, 04:31 PM
MNLOMenlo Therapeutics Inc.Harsch MutyaChief Legal Officer and GCJun 30, 2020Option Exercise$1.731,8223,152318,887Jul 02, 2020, 04:24 PM
MNLOMenlo Therapeutics Inc.Harsch MutyaChief Legal Officer and GCApr 06, 2020Option Exercise$1.404,4746,264170,712Apr 07, 2020, 05:22 PM
MNLOMenlo Therapeutics Inc.Harsch MutyaChief Legal Officer and GCMar 31, 2020Option Exercise$2.681,6884,52456,503Apr 02, 2020, 04:47 PM
FOMXFoamix Pharmaceuticals Ltd.Harsch MutyaCLO and General CounselMar 02, 2020Option Exercise$2.681,7614,71598,232Mar 03, 2020, 12:00 AM
FOMXFoamix Pharmaceuticals Ltd.Harsch MutyaCLO and General CounselDec 31, 2019Option Exercise$3.286182,02755,172Jan 03, 2020, 05:23 PM
FOMXFoamix Pharmaceuticals Ltd.Harsch MutyaCLO and General CounselNov 29, 2019Option Exercise$2.164,2849,24955,790Dec 03, 2019, 04:30 PM
FOMXFoamix Pharmaceuticals Ltd.Harsch MutyaCLO and General CounselSep 30, 2019Option Exercise$3.074631,42151,506Oct 02, 2019, 04:19 PM
FOMXFoamix Pharmaceuticals Ltd.Harsch MutyaCLO and General CounselJul 01, 2019Sale$2.356391,50251,969Jul 03, 2019, 04:28 PM
FOMXFoamix Pharmaceuticals Ltd.Harsch MutyaCLO and General CounselApr 01, 2019Sale$3.752,5199,44652,608Apr 03, 2019, 04:42 PM